Formulation approaches and strategies for transdermal delivery of insulin: special emphasis on microneedle-based systems

Abstract

The prevalence of diabetes is increasing and expected to become a major global health burden. Various pharmaceutical approaches have been used to manage diabetes and reduce the associated risks. Subcutaneous insulin injection remains the primary treatment due to the physicochemical properties of insulin, which limit oral absorption. The gastrointestinal tract presents further challenges, including enzymatic degradation and harsh environmental conditions, resulting in oral insulin bioavailability < 1%. As a result, alternative delivery routes, such as transdermal delivery, have been extensively explored. However, this approach is also challenging due to the structural barriers of the skin, which hinder drug absorption. The high molecular weight of insulin further limits permeation across the skin. To address these limitations, various formulation and delivery strategies have been investigated to improve transdermal drug delivery of insulin and are the subject of this review. Approaches, including penetration enhancers, lipid-based carriers, microemulsion, polymeric systems, and physical enhancement technologies, have demonstrated potential for enhancing skin permeability. However, the potential adverse effects and patient discomfort associated with these conventional methods highlights the need for more user-friendly alternatives. Microneedles have emerged as a promising transdermal delivery system, offering a painless, simple, and user-friendly approach to overcome challenges, thus improving adherence and treatment efficacy.

Keywords

Transdermal delivery systems / Diabetes mellitus formulations / Insulin / Skin penetration enhancers / Liposomes / Niosomes / Transferosomes / Microemulsions / Microneedles

References

[1] Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al.: Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Research and Clinical Practice 2019, 157: 107843.

[2] Snapshot: Diabetes in Australia. 2023. [https://www.diabetesaustralia.com.au/wp-content/uploads/2023-Snapshot-Diabetes-in-Australia.pdf].

[3] Darvishha S, Amiri S: (Trans) Dermal Insulin Delivery Based on Polymeric Systems. International Journal of Polymeric Materials and Polymeric Biomaterials 2019, 68: 1118-1132.

[4] Long L, Zhang J, Yang Z, Guo Y, Hu X, Wang Y: Transdermal Delivery of Peptide and Protein Drugs: Strategies, Advantages and Disadvantages. Journal of Drug Delivery Science and Technology 2020, 60: 102007.

[5] Davies M: The Reality of Glycaemic Control in Insulin Treated Diabetes: Defining the Clinical Challenges. International Journal of Obesity and Related Metabolic Disorders 2004, 28: S14-S22.

[6] Nordquist L, Roxhed N, Griss P, Stemme G: Novel Microneedle Patches for Active Insulin Delivery are Efficient in Maintaining Glycaemic Control: An Initial Comparison with Subcutaneous Administration. Pharmaceutical Research 2007, 24: 1381-1388.

[7] Li H, Shi Y, Ding X, Zhen C, Lin G, Wang F, et al.: Recent Advances in Transdermal Insulin Delivery Technology: A Review. International Journal of Biological Macromolecules 2024, 274(Pt 2): 133452.

[8] Mo R, Jiang T, Di J, Tai W, Gu Z: Emerging Micro- and Nanotechnology Based Synthetic Approaches for Insulin Delivery. Chemical Society Reviews 2014, 43: 3595-3629.

[9] De Meyts P: Insulin and Its Receptor: Structure, Function and Evolution. Bioessays 2004, 26: 1351-1362.

[10] Liu T, Chen M, Fu J, Sun Y, Lu C, Quan G, et al.: Recent Advances in Microneedles-Mediated Transdermal Delivery of Protein and Peptide Drugs. Acta Pharmaceutica Sinica B 2021, 11: 2326-2343.

[11] Han Y, Spicer J, Huang Y, Bunt C, Liu M, Wen J: Advancements in Oral Insulin: A Century of Research and the Emergence of Targeted Nanoparticle Strategies. European Journal of Lipid Science and Technology 2024, 126: 2300271.

[12] Mdanda S, Ubanako P, Kondiah PP, Kumar P, Choonara YE: Recent Advances in Microneedle Platforms for Transdermal Drug Delivery Technologies. Polymers 2021, 13: 2405.

[13] Korytkowski M, Niskanen L, Asakura T: FlexPen: Addressing Issues of Confidence and Convenience in Insulin Delivery. Clinical Therapeutics 2005, 27(Suppl B): S89-S100.

[14] Pickup J, Keen H: Continuous Subcutaneous Insulin Infusion at 25 Years: Evidence Base for the Expanding use of Insulin Pump Therapy in Type 1 Diabetes. Diabetes Care 2002, 25: 593-598.

[15] Zhang Y, Yu J, Kahkoska AR, Wang J, Buse JB, Gu Z: Advances in Transdermal Insulin Delivery. Advanced Drug Delivery Reviews 2019, 139: 51-70.

[16] Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R: Insulin Pump Therapy: A Meta-Analysis. Diabetes Care 2003, 26: 1079-1087.

[17] Owens DR, Zinman B, Bolli G: Alternative Routes of Insulin Delivery. Diabetic Medicine 2003, 20: 886-898.

[18] Owens DR: New Horizons-Alternative Routes for Insulin Therapy. Nature Reviews. Drug Discovery 2002, 1: 529-540.

[19] Wen J, Huang Y: Strategies to Enhance Drug Permeability Across Biological Barriers-A Summary of This Important Special Issue. Pharmaceutics 2023, 15: 1189.

[20] Liu M, Chen S, Zhang Z, Li H, Sun G, Yin N, et al.: Anti-ageing Peptides and Proteins for Topical Applications: A Review. Pharmaceutical Development and Technology 2022, 27: 108-125.

[21] Benson HA: Transdermal Drug Delivery: Penetration Enhancement Techniques. Current Drug Delivery 2005, 2: 23-33.

[22] Kalia YN, Naik A, Garrison J, Guy RH: Iontophoretic Drug Delivery. Advanced Drug Delivery Reviews 2004, 56: 619-658.

[23] Kováčik A, Kopečná M, Vávrová K: Permeation Enhancers in Transdermal Drug Delivery: Benefits and Limitations. Expert Opinion on Drug Delivery 2020, 17: 145-155.

[24] Ashtikar M, Nagarsekar K, Fahr A: Transdermal Delivery from Liposomal Formulations - Evolution of the Technology Over the Last Three Decades. Journal of Controlled Release 2016, 242: 126-140.

[25] Darrington RT, Anderson BD: The Role of Intramolecular Nucleophilic Catalysis and the Effects of Self-association on the Deamidation of Human Insulin at Low pH. Pharmaceutical Research 1994, 11: 784-793.

[26] Velankar S, Best C, Beuth B, Boutselakis CH, Cobley N, Sousa Da Silva AW, et al.: PDBe: Protein Data Bank in Europe. Nucleic Acids Research 2011, 38(suppl 1): D308-D317.

[27] Bolje A, Gobec S . Analytical Techniques for Structural Characterization of Proteins in Solid Pharmaceutical Forms: An Overview. Pharmaceutics 2021, 13: 534.

[28] Ryall C, Duarah S, Chen S, Yu H, Wen J: Advancements in Skin Delivery of Natural Bioactive Products for Wound Management: A Brief Review of Two Decades. Pharmaceutics 2022, 14: 1072.

[29] Hussain Shah SN, Zulcaif, Syed A, Aslam A, Zafar N, Arif A: Development of Film Forming Gel for the Delivery of 5-flurouracil: In-vitro/Ex-vivo Evaluation. Polymer Bulletin 2024, 81: 7121-7137.

[30] Pathan IB, Setty CM: Chemical Penetration Enhancers for Transdermal Drug Delivery Systems. Tropical Journal of Pharmaceutical Research 2009, 8.

[31] Li Y, Quan Y, Zang L, Jin M, Kamiyama F, Katsumi H, et al.: Transdermal Delivery of Insulin Using Trypsin as a Biochemical Enhancer. Biological & Pharmaceutical Bulletin 2008, 1: 1574-1579.

[32] Chen Y, Shen Y, Guo X, Zhang C, Yang W, Ma M, et al.: Transdermal Protein Delivery by a Coadministered Peptide Identified Via Phage Display. Nature Biotechnology 2006, 24: 455-460.

[33] Kogan A, Garti N: Microemulsions as Transdermal Drug Delivery Vehicles. Advances in Colloid and Interface Science 2006, 123-126: 369-385.

[34] Tahara Y, Namatsu K, Kamiya N, Hagimori M, Kamiya S, Arakawa M, et al.: Transcutaneous Immunization by a Solid-in-oil Nanodispersion. Chemical Communications (Cambridge, England) 2010, 46: 9200-9202.

[35] Nose K, Pissuwan D, Goto M, Katayama Y, Niidome T: Gold Nanorods in an Oil-base Formulation for Transdermal Treatment of Type 1 Diabetes in Mice. Nanoscale 2012, 4: 3776-3780.

[36] Pillai O, Panchagnula R: Transdermal Delivery of Insulin from Poloxamer Gel: Ex Vivo and In Vivo Skin Permeation Studies in Rat Using Iontophoresis and Chemical Enhancers. Journal of Controlled Release 2003, 89: 127-140.

[37] Pillai O, Panchagnula R: Transdermal Iontophoresis of Insulin: V. EFFECT of Terpenes. Journal of Controlled Release 2003, 88: 287-296.

[38] Zhang T, Luo X, Xu K, Zhong W: Peptide-containing Nanoformulations: Skin Barrier Penetration and Activity Contribution. Advanced Drug Delivery Reviews 2023, 203: 115139.

[39] Yerramsetty KM, Rachakonda VK, Neely BJ, Madihally SV, Gasem KAM: Effect of Different Enhancers on the Transdermal Permeation of Insulin Analog. International Journal of Pharmaceutics 2010, 398: 83-92.

[40] Sintov AC, Wormser U: Topical Iodine Facilitates Transdermal Delivery of Insulin. Journal of Controlled Release 2007, 118: 185-188.

[41] Wang C, Ruan R, Zhang L, Zhang Y, Zhou W, Lin J, et al.: Role of the Na⁺/K⁺-ATPase Beta-Subunit in Peptide-Mediated Transdermal Drug Delivery . Molecular Pharmaceutics 2015, 12: 1259-1267.

[42] Chang M, Li X, Sun Y, Cheng F, Wang Q, Xie X, et al.: Effect of Cationic Cyclopeptides on Transdermal and Transmembrane Delivery of Insulin. Molecular Pharmaceutics 2013, 10: 951-957.

[43] Reddy YD, Sravani AB, Ravisankar V, Prakash PR, Reddy YS, Bhaskar NV: Transferosomes a Novel Vesicular Carrier for Transdermal Drug Delivery System. Journal of Innovations in Pharmaceutical and Biological Sciences 2015, 2: 193-208.

[44] Jijie R, Barras A, Boukherroub R, Szunerits S: Nanomaterials for Transdermal Drug Delivery: Beyond the State of the Art of Liposomal Structures. Journal of Materials Chemistry B 2017, 5: 8653-8675.

[45] Olusanya TO, Haj Ahmad RR, Ibegbu DM, Smith JR, Elkordy AA: Liposomal Drug Delivery Systems and Anticancer Drugs. Molecules 2018, 23: 907.

[46] Yao X, Bunt C, Liu M, Quek S, Shaw J, Cornish J, et al.: Enhanced Cellular Uptake and Transport of Bovine Lactoferrin Using Pectin-and Chitosan-modified Solid Lipid Nanoparticles. Pharmaceutics 2023, 15: 2168.

[47] Fernández-García R, Lalatsa A, Statts L, Bolás-Fernández F, Ballesteros MP, Serrano DR: Transferosomes as Nanocarriers for Drugs Across the Skin: Quality by Design from Lab to Industrial Scale. International Journal of Pharmaceutics 2020, 573: 118817.

[48] Umbarkar MG: Niosome as a Novel Pharmaceutical Drug Delivery: A Brief Review Highlighting Formulation, Types, Composition and Application. Indian Journal of Pharmaceutical Education & Research 2021, 55: S11.

[49] Chen S, Hanning S, Falconer J, Locke M, Wen J: Recent Advances in Non-Ionic Surfactant Vesicles (Niosomes): Fabrication, Characterization, Pharmaceutical and Cosmetic Applications. European Journal of Pharmaceutics and Biopharmaceutics 2019, 144: 18-39.

[50] Liu M, Svirskis D, Proft T, Loh J, Huang Y, Wen J: Cellular Uptake and Transport Mechanism Investigations of PEGylated Niosomes for Improving the Oral Delivery of Thymopentin. Pharmaceutics 2024, 16: 397.

[51] Abdelkader H, Alani AW, Alany RG: Recent Advances in Non-ionic Surfactant Vesicles (Niosomes): Self-assembly, Fabrication, Characterization, Drug Delivery Applications and Limitations. Drug Delivery 2014, 21: 87-100.

[52] Li D, Martini N, Liu M, Falconer JR, Locke M, Wu Z, et al.: Non-ionic Surfactant Vesicles as a Carrier System for Dermal Delivery of (+)-Catechin and their Antioxidant Effects. Journal of Drug Targeting 2021, 29: 310-322.

[53] Ge X, Wei M, He S, Yuan W: Advances of Non-ionic Surfactant Vesicles (Niosomes) and their Application in Drug Delivery. Pharmaceutics 2019, 11: 55.

[54] Azeem A, Anwer MK, Talegaonkar S: Niosomes in Sustained and Targeted Drug Delivery: Some Recent Advances. Journal of Drug Targeting 2009, 17: 671-689.

[55] Vora B, Khopade AJ, Jain NK: Proniosome Based Transdermal Delivery of Levonorgestrel for Effective Contraception. Journal of Controlled Release 1998, 54: 149-165.

[56] Agarwal R, Katare OP, Vyas SP: Preparation and In Vitro Evaluation of Liposomal/Niosomal Delivery Systems for Antipsoriatic Drug Dithranol. International Journal of Pharmaceutics 2001, 228: 43-52.

[57] Paolino D, Cosco D, Muzzalupo R, Trapasso E, Picci N, Fresta M: Innovative Bola-Surfactant Niosomes as Topical Delivery Systems of 5-Fluorouracil for the Treatment of Skin Cancer. International Journal of Pharmaceutics 2008, 353: 233-242.

[58] Pando D, Gutiérrez G, Coca J, Pazos C: Preparation and Characterization of Niosomes Containing Resveratrol. Journal of Food Engineering 2013, 117: 227-234.

[59] Bissett DL, Robinson LR, Raleigh PS, Miyamoto K, Hakozaki T, Li J, et al.: Reduction in the Appearance of Facial Hyperpigmentation by Topical N-Acetyl Glucosamine. Journal of Cosmetic Dermatology. 2007, 6: 20-26.

[60] Manosroi A, Jantrawut P, Akihisa T, Manosroi W, Manosroi J: In Vitro and In Vivo Skin Anti-aging Evaluation of Gel Containing Niosomes Loaded with a Semi-purified Fraction Containing Gallic Acid from Terminalia Chebula Galls. Pharmaceutical Biology 2011, 49: 1190-1203.

[61] Nasr M, Mansour S, Mortada ND, Elshamy AA: Vesicular Aceclofenac Systems: A Comparative Study Between Liposomes and Niosomes. Journal of Microencapsulation 2008, 25: 499-512.

[62] Manosroi A, Jantrawut P, Manosroi J: Anti-inflammatory Activity of Gel Containing Novel Elastic Niosomes Entrapped with Diclofenac Diethylammonium. International Journal of Pharmaceutics 2008, 360: 156-163.

[63] Hanan M, Omar S, Laila GM: Novel Sugar Esters Proniosomes for Transdermal Delivery of Vinpocetine: Preclinical and Clinical Studies. European Journal of Pharmaceutics and Biopharmaceutics 2011, 77: 43-55.

[64] Patel KK, Kumar P, Thakkar HP: Formulation of Niosomal Gel for Enhanced Transdermal Lopinavir Delivery and Its Comparative Evaluation with Ethosomal Gel. AAPS PharmSciTech 2012, 13: 1502-1510.

[65] Khaksa G, D’Souza R, Lewis S, Udupa N: Pharmacokinetic Study of Niosome Encapsulated Insulin. Indian Journal of Experimental Biology 2000, 38: 901-905.

[66] Ning M, Guo Y, Pan H, Yu H, Gu Z: Niosomes with Sorbitan Monoester as a Carrier for Vaginal Delivery of Insulin: Studies in Rats. Drug Delivery 2005, 12: 399-407.

[67] Pardakhty A, Moazeni E, Varshosaz J, Hajhashemi V, Najafabadi AR: Pharmacokinetic Study of Niosome-loaded Insulin in Diabetic Rats. DARU Journal of Pharmaceutical Sciences 2011, 19: 404.

[68] Natsheh H, Touitou E: Phospholipid Vesicles for Dermal/Transdermal and Nasal Administration of Active Molecules: The Effect of Surfactants and Alcohols on the Fluidity of their Lipid Bilayers and Penetration Enhancement Properties. Molecules 2020, 25: 2959.

[69] Malakar J, Sen SO, Nayak AK, Sen KK: Formulation, Optimization and Evaluation of Transferosomal Gel for Transdermal Insulin Delivery. Saudi Pharmaceutical Journal 2012, 20: 355-363.

[70] Marwah H, Garg T, Rath G, Goyal AK: Development of Transferosomal Gel for Trans-dermal Delivery of Insulin Using Iodine Complex. Drug Delivery 2016, 23: 1636-1644.

[71] Najjar R: Microemulsions: An Introduction to Properties and Applications . BoD-Books on Demand; 2012.

[72] Mitra D: Microemulsion and Its Application: An Inside Story. Materials Today Proceedings 2023, 83: 75-82.

[73] Klier J, Tucker CJ, Kalantar TH, Green DP: Properties and Applications of Microemulsions. Advanced Materials 2000, 12: 1751-1757.

[74] Sane R, Mittapalli RK, Elmquist WF: Development and Evaluation of a Novel Microemulsion Formulation of Elacridar to Improve Its Bioavailability. Journal of Pharmaceutical Sciences 2013, 102: 1343-1354.

[75] Goswami P, Choudhury A, Dey BK: Microemulsion-A Potential Carrier for Improved Bioavailability. International Journal of Pharmaceutical & Biological Archive 2019, 10: 69-77.

[76] Liu M, Sharma M, Lu G, Zhang Z, Yin N, Wen J: Full Factorial Design, Physicochemical Characterization, Ex Vivo Investigation, and Biological Assessment of Glutathione-loaded Solid Lipid Nanoparticles for Topical Application. International Journal of Pharmaceutics 2023, 630: 122381.

[77] Liu M, Wen J, Sharma M: Solid Lipid Nanoparticles for Topical Drug Delivery: Mechanisms, Dosage form Perspectives, and Translational Status. Current Pharmaceutical Design 2020, 26: 3203-3217.

[78] Roohinejad S, Oey I, Everett DW, Greiner R: Microemulsions. Emulsion-based Systems for Delivery of Food Active Compounds: Formation, Application, Health and Safety. 2018: 231-262.

[79] Guo J, Ping Q, Zhang L: Transdermal Delivery of Insulin in Mice by Using Lecithin Vesicles as a Carrier. Drug Delivery 2000, 7: 113-116.

[80] King MJ, Badea I, Solomon J, Kumar P, Gaspar KJ, Foldvari M: Transdermal Delivery of Insulin from a Novel Biphasic Lipid System in Diabetic Rats. Diabetes Technology & Therapeutics 2002, 4: 479-488.

[81] Tahara Y, Honda S, Kamiya N, Goto M: Transdermal Delivery of Insulin Using a Solid-in-oil Nanodispersion Enhanced by Arginine-rich Peptides. MedChemComm 2012, 3: 1496-1499.

[82] Tahara Y, Honda S, Kamiya N, Piao H, Hirata A, Hayakawa E, et al.: A Solid-in-oil Nanodispersion for Transcutaneous Protein Delivery. Journal of Controlled Release 2008, 131: 14-18.

[83] Malakar J, Sen SO, Nayak AK, Sen KK: Development and Evaluation of Microemulsions for Transdermal Delivery of Insulin. ISRN Pharmaceutics 2011, 2011: 780150.

[84] King MJ, Michel D, Foldvari M: Evidence for Lymphatic Transport of Insulin by Topically Applied Biphasic Vesicles. The Journal of Pharmacy and Pharmacology 2003, 55: 1339-1344.

[85] Hussain A, Ahmad Z, Mahmood A, Shchinar S, Khan MI, Akhtar A, et al.: Nystatin, Aspirin and Lidocaine Containing Orodispersible Films for Pronounced Drug Delivery: Development and Characterization. BioNanoScience 2024, 14: 2391-2402.

[86] Ferreira SA, Gama FM, Vilanova M: Polymeric Nanogels as Vaccine Delivery Systems. Nanomedicine 2013, 9: 159-173.

[87] Elçioğlu HK, Sezer AD: Nanoparticle Insulin Drug Delivery-Applications and New Aspects. In Application of Nanotechnology in Drug Delivery. Volume 5. IntechOpen; 2014: 237.

[88] Hulambukie E, Abdeltawab H, Duarah S, Svirskis D, Sharma M: Injectable In Situ Gelling System for Sustained Nicotine Delivery as a Replacement Therapy for Smoking Cessation. Gels 2022, 8: 114.

[89] Duarah S, Sharma M, Wen J: Recent Advances in Microneedle-Based Drug Delivery: Special Emphasis on its use in Paediatric Population. European Journal of Pharmaceutics and Biopharmaceutics 2019, 136: 48-69.

[90] Ling M, Chen M: Dissolving Polymer Microneedle Patches for Rapid and Efficient Transdermal Delivery of Insulin to Diabetic Rats. Acta Biomaterialia 2013, 9: 8952-8961.

[91] Liu S, Jin M-N, Quan Y-S, Kamiyama F, Katsumi H, Sakane T, et al.: The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin. Journal of Controlled Release 2012, 161: 933-941.

[92] Chen M, Ling M, Kusuma SJ: Poly-γ-glutamic Acid Microneedles with a Supporting Structure Design as a Potential Tool for Transdermal Delivery of Insulin. Acta Biomaterialia 2015, 24: 106-116.

[93] Lau S, Fei J, Liu H, Chen W, Liu R: Multilayered Pyramidal Dissolving Microneedle Patches with Flexible Pedestals for Improving Effective Drug Delivery. Journal of Controlled Release 2017, 265: 113-119.

[94] Liu D, Yu B, Jiang G, Yu W, Zhang Y, Xu B: Fabrication of Composite Microneedles Integrated with Insulin-loaded CaCO₃ Microparticles and PVP for Transdermal Delivery in Diabetic Rats . Materials Science and Engineering: C 2018, 90: 180-188.

[95] Seong K, Seo M, Hwang DY, O’Cearbhaill ED, Sreenan S, Karp JM, et al.: A Self-adherent, Bullet-shaped Microneedle Patch for Controlled Transdermal Delivery of Insulin. Journal of Controlled Release 2017, 265: 48-56.

[96] Zhang Y, Jiang G, Yu W, Liu D, Xu B: Microneedles Fabricated from Alginate and Maltose for Transdermal Delivery of Insulin on Diabetic Rats. Materials Science and Engineering: C 2018, 85: 18-26.

[97] Di J, Yao S, Ye Y, Cui Z, Yu J, Ghosh TK, et al.: Stretch-triggered Drug Delivery From Wearable Elastomer Films Containing Therapeutic Depots. ACS Nano 2015, 9: 9407-9415.

[98] Yang S, Wu F, Liu J, Fan G, Welsh W, Zhu H, et al.: Phase-Transition Microneedle Patches for Efficient and Accurate Transdermal Delivery of Insulin. Advanced Functional Materials 2015, 25: 4633-4641.

[99] Yu W, Jiang G, Liu D, Li L, Tong Z, Yao J, et al.: Transdermal Delivery of Insulin with Bioceramic Composite Microneedles Fabricated by Gelatin and Hydroxyapatite. Materials Science and Engineering: C 2017, 73: 425-428.

[100] Yu W, Jiang G, Liu D, Li L, Chen H, Liu Y, et al.: Fabrication of Biodegradable Composite Microneedles Based on Calcium Sulfate and Gelatin for Transdermal Delivery of Insulin. Materials Science and Engineering: C 2017, 71: 725-734.

[101] Li JY, Feng YH, He YT, Hu LF, Liang L, Zhao ZQ, et al.: Thermosensitive Hydrogel Microneedles for Controlled Transdermal Drug Delivery. Acta Biomaterialia 2022, 153: 308-319.

[102] Yu J, Zhang Y, Ye Y, DiSanto R, Sun W, Ranson D, et al.: Microneedle-Array Patches Loaded with Hypoxia-Sensitive Vesicles Provide Fast Glucose-Responsive Insulin Delivery. Proceedings of the National Academy of Sciences of the United States of America 2015, 112: 8260-8265.

[103] Sadhasivam L, Dey N, Francis AP, Devasena T: Transdermal Patches of Chitosan Nanoparticles for Insulin Delivery. International Journal of Pharmacy and Pharmaceutical Sciences 2015, 7: 84-88.

[104] Chen C, Shyu VB, Chen C: Dissolving Microneedle Patches for Transdermal Insulin Delivery in Diabetic Mice: Potential for Clinical Applications. Materials 2018, 11: 1625.

[105] Lee I, Lin W, Shu J, Tsai S, Chen C, Tsai M: Formulation of Two-Layer Dissolving Polymeric Microneedle Patches for Insulin Transdermal Delivery in Diabetic Mice. Journal of Biomedical Materials Research. Part A 2017, 105: 84-93.

[106] Zhang N, Zhou X, Liu L, Zhao L, Xie H, Yang Z: Dissolving Polymer Microneedles for Transdermal Delivery of Insulin. Frontiers in Pharmacology 2021, 12: 719905.

[107] Wang Y, Wang H, Zhu XX, Guan Y, Zhang Y: Smart Microneedle Patches for Rapid, and Painless Transdermal Insulin Delivery. Journal of Materials Chemistry B 2020, 8: 9335-9342.

[108] Yang H, Kim S, Huh I, Kim S, Lahiji SF, Kim M, et al.: Rapid Implantation of Dissolving Microneedles on an Electrospun Pillar Array. Biomaterials 2015, 64: 70-77.

[109] Garland MJ, Caffarel-Salvador E, Migalska K, Woolfson AD, Donnelly RF: Dissolving Polymeric Microneedle Arrays for Electrically Assisted Transdermal Drug Delivery. Journal of Controlled Release 2012, 159: 52-59.

[110] Kim JD, Kim M, Yang H, Lee K, Jung H: Droplet-Born Air Blowing: Novel Dissolving Microneedle Fabrication. Journal of Controlled Release 2013, 170: 430-436.

[111] Lee I, Wu Y, Tsai S, Chen C, Wu M: Fabrication of Two-Layer Dissolving Polyvinylpyrrolidone Microneedles with Different Molecular Weights for In Vivo Insulin Transdermal Delivery. RSC Advances 2017, 7: 5067-5075.

[112] Garg T, Kumar Goyal A: Iontophoresis: Drug Delivery System by Applying an Electrical Potential Across the Skin. Drug Delivery Letters 2012, 2: 270-280.

[113] Pillai O, Kumar N, Dey CS, Borkute S, Nagalingam S, Panchagnula R: Transdermal Iontophoresis of Insulin. Part 1: A Study on the Issues Associated with the use of Platinum Electrodes on Rat Skin. The Journal of Pharmacy and Pharmacology 2003, 55: 1505-1513.

[114] Panchagnula R, Bindra P, Kumar N, Shanker Dey C, Pillai O: Stability of Insulin Under Iontophoretic Conditions. Die Pharmazie 2006, 61: 1014-1018.

[115] Kajimoto K, Yamamoto M, Watanabe M, Kigasawa K, Kanamura K, Harashima H, et al.: Noninvasive and Persistent Transfollicular Drug Delivery System Using a Combination of Liposomes and Iontophoresis. International Journal of Pharmaceutics 2011, 403: 57-65.

[116] Xu X, Zhang H, Yan Y, Wang J, Guo L: Effects of Electrical Stimulation on Skin Surface. Acta Mechanica Sinica 2021, 37: 1843-1871.

[117] Yan G, Peck KD, Zhu H, Higuchi WI, Li SK: Effects of Electrophoresis and Electroosmosis During Alternating Current Iontophoresis Across Human Epidermal Membrane. Journal of Pharmaceutical Sciences 2005, 94: 547-558.

[118] Pikal MJ: The Role of Electroosmotic Flow in Transdermal Iontophoresis. Advanced Drug Delivery Reviews 2001, 46: 281-305.

[119] Sieg A, Jeanneret F, Fathi M, Hochstrasser D, Rudaz S, Veuthey J, et al.: Extraction of Amino Acids by Reverse Iontophoresis In Vivo . European Journal of Pharmaceutics and Biopharmaceutics 2009, 72: 226-231.

[120] Naik A, Kalia YN, Guy RH: Transdermal Drug Delivery: Overcoming the Skin’s Barrier Function. Pharmaceutical Science & Technology Today 2000, 3: 318-326.

[121] Tokumoto S, Higo N, Sugibayashi K: Effect of Electroporation and pH on the Iontophoretic Transdermal Delivery of Human Insulin. International Journal of Pharmaceutics 2006, 326: 13-19.

[122] Murdan S: Electro-Responsive Drug Delivery from Hydrogels. Journal of Controlled Release 2003, 92: 1-17.

[123] Chen X, Zhu L, Li R, Pang L, Zhu S, Ma J, et al.: Electroporation-Enhanced Transdermal Drug Delivery: Effects of logP, pK_a, Solubility and Penetration Time . European Journal of Pharmaceutical Sciences 2020, 151: 105410.

[124] Kougkolos G, Laudebat L, Dinculescu S, Simon J, Golzio M, Valdez-Nava Z, et al.: Skin Electroporation for Transdermal Drug Delivery: Electrical Measurements, Numerical Model and Molecule Delivery. Journal of Controlled Release 2024, 367: 235-247.

[125] Mohammad EA, Elshemey WM, Elsayed AA, Abd-Elghany AA: Electroporation Parameters for Successful Transdermal Delivery of Insulin. American Journal of Therapeutics 2016, 23: e1560-e1567.

[126] Rastogi R, Anand S, Koul V: Electroporation of Polymeric Nanoparticles: An Alternative Technique for Transdermal Delivery of Insulin. Drug Development and Industrial Pharmacy 2010, 36: 1303-1311.

[127] Sen A, Zhao Y, Zhang L, Hui SW: Enhanced Transdermal Transport by Electroporation Using Anionic Lipids. Journal of Controlled Release 2002, 82: 399-405.

[128] Azagury A, Khoury L, Enden G, Kost J: Ultrasound Mediated Transdermal Drug Delivery. Advanced Drug Delivery Reviews 2014, 72: 127-143.

[129] Boucaud A, Garrigue MA, Machet L, Vaillant L, Patat F: Effect of Sonication Parameters on Transdermal Delivery of Insulin to Hairless Rats. Journal of Controlled Release 2002, 81: 113-119.

[130] Park E, Dodds J, Smith NB: Dose Comparison of Ultrasonic Transdermal Insulin Delivery to Subcutaneous Insulin Injection. International Journal of Nanomedicine 2008, 3: 335-341.

[131] Park EJ, Werner J, Smith NB: Ultrasound Mediated Transdermal Insulin Delivery in Pigs Using a Lightweight Transducer. Pharmaceutical Research 2007, 24: 1396-1401.

[132] Park EJ, Werner J, Jaiswal D, Smith NB: Closed-Loop Controlled Noninvasive Ultrasonic Glucose Sensing and Insulin Delivery. In AIP Conference Proceedings. American Institute of Physics; 2010: 157-160.

[133] Di J, Price J, Gu X, Jiang X, Jing Y, Gu Z: Ultrasound-Triggered Regulation of Blood Glucose Levels Using Injectable Nano-Network. Advanced Healthcare Materials 2014, 3: 811-816.

[134] Di J, Yu J, Wang Q, Yao S, Suo D, Ye Y, et al.: Ultrasound-Triggered Noninvasive Regulation of Blood Glucose Levels Using Microgels Integrated with Insulin Nanocapsules. Nano Research 2017, 10: 1393-1402.

[135] Castellanos IS, Jeremic A, Cohen J, Zderic V: Ultrasound Stimulation of Insulin Release from Pancreatic Beta Cells as a Potential Novel Treatment for Type 2 Diabetes. Ultrasound in Medicine & Biology 2017, 43: 1210-1222.

[136] Suarez Castellanos I, Singh T, Balteanu B, Bhowmick DC, Jeremic A, Zderic V: Calcium-Dependent Ultrasound Stimulation of Secretory Events from Pancreatic Beta Cells. Journal of Therapeutic Ultrasound 2017, 5: 1-13.

[137] Engwerda EE, Tack CJ, De Galan BE: Needle-Free Jet Injection of Rapid-Acting Insulin Improves Early Postprandial Glucose Control in Patients with Diabetes. Diabetes Care 2013, 36: 3436-3441.

[138] Hu J, Shi H, Zhao C, Li X, Wang Y, Cheng Q, et al.: Lispro Administered by the QS-M Needle-Free Jet Injector Generates an Earlier Insulin Exposure. Expert Opinion on Drug Delivery 2016, 13: 1203-1207.

[139] Mohizin A, Lee D, Kim JK: Impact of the Mechanical Properties of Penetrated Media on the Injection Characteristics of Needle-Free Jet Injection. Experimental Thermal and Fluid Science 2021, 126: 110396.

[140] Bremseth DL, Pass F: Delivery of Insulin by Jet Injection: Recent Observations. Diabetes Technology & Therapeutics 2001, 3: 225-232.

[141] Arora A, Hakim I, Baxter J, Rathnasingham R, Srinivasan R, Fletcher DA, et al.: Needle-Free Delivery of Macromolecules Across the Skin by Nanoliter-Volume Pulsed Microjets. Proceedings of the National Academy of Sciences of the United States of America 2007, 104: 4255-4260.

[142] Duarah S, Sharma M, Chen S, Proft TK, Loh J, Wen J: Design, Optimization and Evaluation of Dexamethasone-Loaded Microneedles for Inflammatory Disorders. International Journal of Pharmaceutics 2023, 635: 122690.

[143] Ijaz R, Ahmad Z, Khan MI, Usmani SJ, Sarwar HS, Sohail MF: Revolutionizing Hypertension Management: Cutting-Edge Microneedle Patch Infused with Zinc Oxide Nanoparticles for Advanced Transdermal Drug Delivery. BioNanoScience 2024, 14: 1397-1409.

[144] Altaf Z, Ahmad Z, Mahmood A, Shchinar S, Latif R: Dissolving Microneedle Patch for Transdermal Delivery of Perindopril Erbumine. Inflammopharmacology 2025, 33: 1381-1391.

[145] Ali S, Ahmad Z, Mahmood A, Khan MI, Siddique W, Latif R, et al.: Enhanced Transdermal Drug Delivery of Labetalol via Nanoparticle-Loaded Dissolvable Microneedle Patches. BioNanoScience 2025, 15: 181.

[146] Martínez-Navarrete M, Pérez-López A, Guillot AJ, Cordeiro AS, Melero A, Aparicio-Blanco J: Latest Advances in Glucose-Responsive Microneedle-Based Systems for Transdermal Insulin Delivery. International Journal of Biological Macromolecules 2024, 263: 130301.

[147] Ko P, Lee I, Chen M, Tsai S: Polymer Microneedles Fabricated from PCL and PCL/PEG Blends for Transdermal Delivery of Hydrophilic Compounds. Journal of the Taiwan Institute of Chemical Engineers 2015, 51: 1-8.

[148] Waghule T, Singhvi G, Dubey SK, Pandey MM, Gupta G, Singh M, et al.: Microneedles: A Smart Approach and Increasing Potential for Transdermal Drug Delivery System. Biomedicine & Pharmacotherapy 2019, 109: 1249-1258.

[149] Xie Y, Xu B, Gao Y: Controlled Transdermal Delivery of Model Drug Compounds by MEMS Microneedle Array. Nanomedicine: Nanotechnology, Biology and Medicine 2005, 1: 184-190.

[150] Moon SJ, Lee SS: A Novel Fabrication Method of a Microneedle Array Using Inclined Deep X-ray Exposure. Journal of Micromechanics and Microengineering 2005, 15: 903.

[151] Wilke N, Mulcahy A, Ye S-R, Morrissey A: Process Optimization and Characterization of Silicon Microneedles Fabricated by Wet Etch Technology. Microelectronics Journal 2005, 36: 650-656.

[152] Ji J, Tay FE, Miao J, Iliescu C: Microfabricated Silicon Microneedle Array for Transdermal Drug Delivery. Journal of Physics: Conference Series 2006, 34: 1127.

[153] Tao SL, Desai TA: Microfabricated Drug Delivery Systems: From Particles to Pores. Advanced Drug Delivery Reviews 2003, 55: 315-328.

[154] Madou MJ: Fundamentals of Microfabrication: The Science of Miniaturization . CRC Press; 2018.

[155] Banks D: Microengineering, MEMS, and Interfacing: A Practical Guide . CRC Press; 2006.

[156] Park J, Yoon Y, Choi S, Prausnitz MR, Allen MG: Tapered Conical Polymer Microneedles Fabricated Using an Integrated Lens Technique for Transdermal Drug Delivery. IEEE Transactions on Bio-Medical Engineering 2007, 54: 903-913.

[157] Kim K, Park DS, Lu HM, Che W, Kim K, Lee J, et al: A Tapered Hollow Metallic Microneedle Array Using Backside Exposure of SU-8. Journal of Micromechanics and Microengineering 2004, 14: 597.

[158] Kim H, Theogarajan LS, Pennathur S: A Repeatable and Scalable Fabrication Method for Sharp, Hollow Silicon Microneedles. Journal of Micromechanics and Microengineering 2018, 28: 035007.

[159] Wei-Ze L, Mei-Rong H, Jian-Ping Z, Yong-Qiang Z, Bao-Hua H, Ting L, et al.: Super-Short Solid Silicon Microneedles for Transdermal Drug Delivery Applications. International Journal of Pharmaceutics 2010, 389: 122-129.

[160] Qiu Y, Gao Y, Hu K, Li F: Enhancement of Skin Permeation of Docetaxel: A Novel Approach Combining Microneedle and Elastic Liposomes. Journal of Controlled Release 2008, 129: 144-150.

[161] Suner S, Fellows MR, Vargas-Irwin C, Nakata GK, Donoghue JP: Reliability of Signals from a Chronically Implanted, Silicon-Based Electrode Array in Non-Human Primate Primary Motor Cortex. IEEE Transactions on Neural Systems and Rehabilitation Engineering 2005, 13: 524-541.

[162] Kelly RC, Smith MA, Samonds JM, Kohn A, Bonds AB, Movshon JA, et al.: Comparison of Recordings from Microelectrode Arrays and Single Electrodes in the Visual Cortex. Journal of Neuroscience 2007, 27: 261-264.

[163] Cormier M, Johnson B, Ameri M, Nyam K, Libiran L, Zhang DD, et al.: Transdermal Delivery of Desmopressin Using a Coated Microneedle Array Patch System. Journal of Controlled Release 2004, 97: 503-511.

[164] Aoyagi S, Izumi H, Fukuda M: Biodegradable Polymer Needle with Various Tip Angles and Consideration on Insertion Mechanism of Mosquito’s Proboscis. Sensors and Actuators A: Physical 2008, 143: 20-28.

[165] Ding Z, Verbaan FJ, Bivas-Benita M, Bungener L, Huckriede A, van den Berg DJ, et al.: Microneedle Arrays for the Transcutaneous Immunization of Diphtheria and Influenza in BALB/c Mice. Journal of Controlled Release 2009, 136: 71-78.

[166] Verbaan FJ, Bal SM, van den Berg DJ, Dijksman JA, van Hecke M, Verpoorten H, et al.: Improved Piercing of Microneedle Arrays in Dermatomed Human Skin by an Impact Insertion Method. Journal of Controlled Release 2008, 128: 80-88.

[167] Wermeling DP, Banks SL, Hudson DA, Gill HS, Gupta J, Prausnitz MR, et al.: Microneedles Permit Transdermal Delivery of a Skin-Impermeant Medication to Humans. Proceedings of the National Academy of Sciences of the United States of America 2008, 105: 2058-2063.

[168] Chen Z, Ren L, Li J, Yao L, Chen Y, Liu B, et al.: Rapid Fabrication of Microneedles Using Magnetorheological Drawing Lithography. Acta Biomaterialia 2018, 65: 283-291.

[169] Davis SP, Martanto W, Allen MG, Prausnitz MR: Hollow Metal Microneedles for Insulin Delivery to Diabetic Rats. IEEE Transactions on Biomedical Engineering 2005, 52: 909-915.

[170] Gardeniers HJ, Luttge R, Berenschot EJ, De Boer MJ, Yeshurun SY, Hefetz M, et al.: Silicon Micromachined Hollow Microneedles for Transdermal Liquid Transport. Journal of Microelectromechanical Systems 2003, 12: 855-862.

[171] Roxhed N, Gasser TC, Griss P, Holzapfel GA, Stemme G: Penetration-Enhanced Ultrasharp Microneedles and Prediction on Skin Interaction for Efficient Transdermal Drug Delivery. Journal of Microelectromechanical Systems 2007, 16: 1429-1440.

[172] Perennes F, Marmiroli B, Matteucci M, Tormen M, Vaccari L, Di Fabrizio E: Sharp Beveled Tip Hollow Microneedle Arrays Fabricated by LIGA and 3D Soft Lithography with Polyvinyl Alcohol. Journal of Micromechanics and Microengineering 2006, 16: 473.

[173] Luttge R, Berenschot EJ, de Boer MJ, Altpeter DM, Vrouwe EX, van den Berg A, et al.: Integrated Lithographic Molding for Microneedle-Based Devices. Journal of Microelectromechanical Systems 2007, 16: 872-884.

[174] Ma B, Liu S, Gan Z, Liu G, Cai X, Zhang H, et al.: A PZT Insulin Pump Integrated with a Silicon Micro Needle Array for Transdermal Drug Delivery. In 56th Electronic Components and Technology Conference 2006. IEEE; 2006: 5.

[175] Yu LM, Tay FEH, Guo DG, Xu L, Yap KL: A Microfabricated Electrode with Hollow Microneedles for ECG Measurement. Sensors and Actuators A: Physical 2009, 151: 17-22.

[176] Baron N, Passave J, Guichardaz B, Cabodevila G: Investigations of Development Process of High Hollow Beveled Microneedles Using a Combination of ICP RIE and Dicing Saw. Microsystems Technology 2008, 14: 1475-1480.

[177] Wang PM, Cornwell M, Hill J, Prausnitz MR: Precise Microinjection into Skin Using Hollow Microneedles. Journal of Investigative Dermatology 2006, 126: 1080-1087.

[178] Daugimont L, Baron N, Vandermeulen G, Pavselj N, Miklavcic D, Jullien M, et al.: Hollow Microneedle Arrays for Intradermal Drug Delivery and DNA Electroporation. The Journal of Membrane Biology 2010, 236: 117-125.

[179] Khumpuang S, Horade M, Fujioka K, Sugiyama S: Geometrical Strengthening and Tip-Sharpening of a Microneedle Array Fabricated by X-ray Lithography. Microsystems Technology 2007, 13: 209-214.

[180] Miller PR, Gittard SD, Edwards TL, Lopez DM, Xiao X, Wheeler DR, et al.: Integrated Carbon Fiber Electrodes Within Hollow Polymer Microneedles for Transdermal Electrochemical Sensing. Biomicrofluidics 2011, 5: 13415.

[181] Gittard SD, Ovsianikov A, Chichkov BN, Doraiswamy A, Narayan RJ: Two-Photon Polymerization of Microneedles for Transdermal Drug Delivery. Expert Opinion on Drug Delivery 2010, 7: 513-533.

[182] Lee K, Lee HC, Lee D, Jung H: Drawing Lithography: Three-Dimensional Fabrication of an Ultrahigh-Aspect-Ratio Microneedle. Advanced Materials 2010, 22: 483-486.

[183] Jung PG, Lee TW, Oh DJ, Hwang SJ, Jung I, Lee S, et al.: Nickel Microneedles Fabricated by Sequential Copper and Nickel Electroless Plating and Copper Chemical Wet Etching. Sensors and Materials 2008, 20: 45-53.

[184] Ito Y, Hagiwara E, Saeki A, Sugioka N, Takada K: Feasibility of Microneedles for Percutaneous Absorption of Insulin. European Journal of Pharmaceutical Sciences 2006, 29: 82-88.

[185] Ito Y, Yoshimitsu J, Shiroyama K, Sugioka N, Takada K: Self-Dissolving Microneedles for the Percutaneous Absorption of EPO in Mice. Journal of Drug Targeting 2006, 14: 255-261.

[186] Min J, Park J, Yoon HH, Choy YB: Ultrasonic Welding Method to Fabricate Polymer Microstructure Encapsulating Protein with Minimum Damage. Macromolecular Research 2008, 16: 570-573.

[187] Park J, Choi S, Kamath R, Yoon Y, Allen MG, Prausnitz MR: Polymer Particle-Based Micromolding to Fabricate Novel Microstructures. Biomedical Microdevices 2007, 9: 223-234.

[188] Huh I, Kim S, Yang H, Jang M, Kang G, Jung H: Effects of Two Droplet-Based Dissolving Microneedle Manufacturing Methods on the Activity of Encapsulated Epidermal Growth Factor and Ascorbic Acid. European Journal of Pharmaceutical Sciences 2018, 114: 285-292.

[189] Martanto W, Davis SP, Holiday NR, Wang J, Gill HS, Prausnitz MR: Transdermal Delivery of Insulin Using Microneedles In Vivo. Pharmaceutical Research 2004, 21: 947-952.

[190] Zhou C, Liu Y, Wang H, Zhang P, Zhang J: Transdermal Delivery of Insulin Using Microneedle Rollers In Vivo. International Journal of Pharmaceutics 2010, 392: 127-133.

[191] Wu Y, Gao Y, Qin G, Zhang S, Qiu Y, Li F, et al.: Sustained Release of Insulin Through Skin by Intradermal Microdelivery System. Biomedical Microdevices 2010, 12: 665-671.

[192] Chen H, Zhu H, Zheng J, Mou D, Wan J, Zhang J, et al.: Iontophoresis-Driven Penetration of Nanovesicles Through Microneedle-Induced Skin Microchannels for Enhancing Transdermal Delivery of Insulin. Journal of Controlled Release 2009, 139: 63-72.

[193] McAllister DV, Wang PM, Davis SP, Park J, Canatella PJ, Allen MG, et al.: Microfabricated Needles for Transdermal Delivery of Macromolecules and Nanoparticles: Fabrication Methods and Transport Studies. Proceedings of the National Academy of Sciences of the United States of America 2003, 100: 13755-13760.

[194] Resnik D, Možek M, Pečar B, Janež A, Urbančič V, Iliescu C, et al.: In Vivo Experimental Study of Noninvasive Insulin Microinjection Through Hollow Si Microneedle Array. Micromachines 2018, 9: 40.

[195] Roxhed N, Samel B, Nordquist L, Griss P, Stemme G: Painless Drug Delivery Through Microneedle-Based Transdermal Patches Featuring Active Infusion. IEEE Transactions on Biomedical Engineering 2008, 55: 1063-1071.

[196] Kochba E, Levin Y, Raz I, Cahn A: Improved Insulin Pharmacokinetics Using a Novel Microneedle Device for Intradermal Delivery in Patients with Type 2 Diabetes. Diabetes Technology & Therapeutics 2016, 18: 525-531.

[197] Martin CJ, Allender CJ, Brain KR, Morrissey A, Birchall JC: Low Temperature Fabrication of Biodegradable Sugar Glass Microneedles for Transdermal Drug Delivery Applications. Journal of Controlled Release 2012, 158: 93-101.

[198] Lee K, Lee CY, Jung H: Dissolving Microneedles for Transdermal Drug Administration Prepared by Stepwise Controlled Drawing of Maltose. Biomaterials 2011, 32: 3134-3140.

[199] Lee JW, Choi S, Felner EI, Prausnitz MR: Dissolving Microneedle Patch for Transdermal Delivery of Human Growth Hormone. Small 2011, 7: 531-539.

[200] Miyano T, Tobinaga Y, Kanno T, Matsuzaki Y, Takeda H, Wakui M, et al.: Sugar Micro Needles as Transdermic Drug Delivery System. Biomedical Microdevices 2005, 7: 185-188.

[201] Sharma S, Hatware K, Bhadane P, Sindhikar S, Mishra DK: Recent Advances in Microneedle Composites for Biomedical Applications: Advanced Drug Delivery Technologies. Materials Science and Engineering: C 2019, 103: 109717.

[202] Hong X, Wei L, Wu F, Wu Z, Chen L, Liu Z, et al.: Dissolving and Biodegradable Microneedle Technologies for Transdermal Sustained Delivery of Drug and Vaccine. Drug Design, Development and Therapy 2013, 7: 945-952.

[203] Ryall C, Chen S, Duarah S, Wen J: Chitosan-Based Microneedle Arrays for Dermal Delivery of Centella Asiatica. International Journal of Pharmaceutics 2022, 627: 122221.

[204] Liu M, Sharma M, Lu G, Zhang Z, Song W, Wen J: Innovative Solid Lipid Nanoparticle-Enriched Hydrogels for Enhanced Topical Delivery of L-Glutathione: A Novel Approach to Anti-Ageing. Pharmaceutics 2024, 17: 4.

[205] Ye Y, Yu J, Wen D, Kahkoska AR, Gu Z: Polymeric Microneedles for Transdermal Protein Delivery. Advanced Drug Delivery Reviews 2018, 127: 106-118.

[206] Park J, Allen MG, Prausnitz MR: Polymer Microneedles for Controlled-Release Drug Delivery. Pharmaceutical Research 2006, 23: 1008-1019.

[207] Hu X, Yu J, Qian C, Lu Y, Kahkoska AR, Xie Z, et al.: H₂O₂-Responsive Vesicles Integrated with Transcutaneous Patches for Glucose-Mediated Insulin Delivery . ACS Nano 2017, 11: 613-620.

[208] Xu B, Jiang G, Yu W, Liu D, Zhang Y, Zhou J, et al.: H₂O₂-Responsive Mesoporous Silica Nanoparticles Integrated with Microneedle Patches for the Glucose-Monitored Transdermal Delivery of Insulin . Journal of Materials Chemistry B 2017, 5: 8200-8208.

[209] Xu B, Cao Q, Zhang Y, Yu W, Zhu J, Liu D, et al.: Microneedles Integrated with ZnO Quantum-Dot-Capped Mesoporous Bioactive Glasses for Glucose-Mediated Insulin Delivery. ACS Biomaterials Science & Engineering 2018, 4: 2473-2483.

[210] Tong Z, Zhou J, Zhong J, Tang Q, Lei Z, Luo H, et al.: Glucose- and H₂O₂-Responsive Polymeric Vesicles Integrated with Microneedle Patches for Glucose-Sensitive Transcutaneous Delivery of Insulin in Diabetic Rats . ACS Applied Materials & Interfaces 2018, 10: 20014-20024.

[211] Yu J, Qian C, Zhang Y, Cui Z, Zhu Y, Shen Q, et al.: Hypoxia and H₂O₂ Dual-Sensitive Vesicles for Enhanced Glucose-Responsive Insulin Delivery . Nano Letters 2017, 17: 733-739.

[212] Wang J, Ye Y, Yu J, Kahkoska AR, Zhang X, Wang C, et al.: Core-Shell Microneedle Gel for Self-Regulated Insulin Delivery. ACS Nano 2018, 12: 2466-2473.

[213] Zhang Y, Wang J, Yu J, Wen D, Kahkoska AR, Lu Y, et al.: Bioresponsive Microneedles with a Sheath Structure for H₂O₂ and pH Cascade-Triggered Insulin Delivery . Small 2018, 14: e1704181.

[214] Ye Y, Yu J, Wang C, Nguyen NY, Walker GM, Buse JB, et al.: Microneedles Integrated with Pancreatic Cells and Synthetic Glucose-Signal Amplifiers for Smart Insulin Delivery. Advanced Materials (Deerfield Beach, Fla.) 2016, 28: 3115-3121.

[215] Ravaine V, Ancla C, Catargi B: Chemically Controlled Closed-Loop Insulin Delivery. Journal of Controlled Release 2008, 132: 2-11.

[216] Hovorka R: Closed-Loop Insulin Delivery: From Bench to Clinical Practice. Nature Reviews. Endocrinology 2011, 7: 385-395.

[217] Yu J, Zhang Y, Bomba H, Gu Z: Stimuli-Responsive Delivery of Therapeutics for Diabetes Treatment. Bioengineering & Translational Medicine 2016, 1: 323-337.

[218] Lu Y, Aimetti AA, Langer R, Gu Z: Bioresponsive Materials. Nature Reviews Materials 2016, 2: 1-17.

[219] Sun W, Hu Q, Ji W, Wright G, Gu Z: Leveraging Physiology for Precision Drug Delivery. Physiological Reviews 2017, 97: 189-225.

[220] Wang J, Zhang Y, Archibong E, Ligler FS, Gu Z: Leveraging H₂O₂ Levels for Biomedical Applications . Advanced Biosystems 2017, 1: 1700084.

[221] Norman JJ, Brown MR, Raviele NA, Prausnitz MR, Felner EI: Faster Pharmacokinetics and Increased Patient Acceptance of Intradermal Insulin Delivery Using a Single Hollow Microneedle in Children and Adolescents with Type 1 Diabetes. Pediatric Diabetes 2013, 14: 459-465.

[222] Pettis RJ, Hirsch L, Kapitza C, Nosek L, Hövelmann U, Kurth H, et al.: Microneedle-Based Intradermal Versus Subcutaneous Administration of Regular Human Insulin or Insulin Lispro: Pharmacokinetics and Postprandial Glycemic Excursions in Patients with Type 1 Diabetes. Diabetes Technology & Therapeutics 2011, 13: 443-450.